Rolapitant Is a Reversible Inhibitor of CYP2D6

Rolapitant [(Varubi), 5S,8S)-8-[[(1R)-1-[3,5 bis(trifluoromethyl phenyl]ethoxy]methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one] is a high-affinity NK1 receptor antagonist that was approved in September 2015 as a treatment for nausea and vomiting caused by chemotherapy. In vivo rolapitant moderately...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Metab Dispos
Main Authors: Glass, Sarah M., Leddy, Sabrina M., Orwin, Michael C., Miller, Garret P., Furge, Kyle A., Furge, Laura Lowe
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Pharmacology and Experimental Therapeutics 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6505376/
https://ncbi.nlm.nih.gov/pubmed/30952677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.118.085928
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados